<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CEFMETAZOLE</span><br/>(sef-met'a-zol)<br/><span class="topboxtradename">Zefazone<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">third-generation cephalosporin</span><br/><b>Prototype: </b>Cefotaxime sodium<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1 g, 2 g injection</p>
<h1><a name="action">Actions</a></h1>
<p>Cefmetazole is a synthetic cephalosporin antibiotic. Its bactericidal action results from inhibition of cell wall synthesis.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Active against a wide range of gram-positive and gram-negative aerobic and anaerobic bacteria. Effectively treats abdominal
         and respiratory tract infections, pelvic inflammatory disease, urinary tract infections, skin and soft tissue infections and
         used for surgical prophylaxis, reducing or eliminating signs and symptoms of infection.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>UTI infections caused by <i>Escherichia coli,</i> lower respiratory tract infections, namely pneumonia and bronchitis caused by <i>Streptococcus pneumoniae, Staphylococcus aureus, E. coli, Haemophilus influenzae</i>. In addition, it is effective against <i>Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus agalactiae, Proteus vulgaris,</i> and <i>Bacteroides fragilis;</i> preoperative prophylaxis of cesarean section, hysterectomy, cholecystectomy, and colorectal surgery.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Patients with known allergy to cefmetazole or to any other cephalosporin antibiotic.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Allergy to penicillin, history of colitis, renal insufficiency, pregnancy (category B), lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Systemic Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 12 g q612h<br/><br/><span class="indicationtitle">Surgical Prophylaxis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 12 g 3090 min before surgery; then q8h for 2 more doses<br/><br/><span class="impairmenttitle">Adjustment for Renal Impairment</span><br/>Cl<sub>cr</sub> <br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">Direct/</span><span class="methodtype">Intermittent:</span> Reconstitute with sterile water for injection, bacteriostatic water for injection, or NS. Dilute 1 g with 3.7 mL to yield
                  250 mg/mL or with 10 mL to yield 100 mg/mL. Dilute 2 g with 7 mL to yield 250 mg/mL or with 15 mL to yield 125 mg/mL. Solution
                  may be further diluted to concentrations ranging from 120 mg/mL by adding it to D5W, NS, or RL.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Direct/</span><span class="methodtype">Intermittent:</span> Drug can be given direct IV over 35 min (for surgical prophylaxis only) or infused over 1060 min.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype"> Solution/additive:</span>
<span class="classification">aminoglycosides</span>. <span class="incompattype">Y-site:</span>
<span class="classification">aminoglycosides</span>. 
               </p>
<ul>
<li>Observe IV sites for evidence of inflammatory reaction. Risk of phlebitis may be reduced by use of a small needle in a large
                     vein.
                  </li>
</ul>
</td>
</tr>
</table>
<ul>
<li>Potency is retained for 24 h after reconstitution at room temperature, 7 d under refrigeration, and for 6 wk if frozen. Store
            away from heat, light, and moisture; do not refreeze.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Hypersensitivity reactions. <span class="typehead">GI:</span>
<span class="speceff-common">Diarrhea,</span> loose stools, nausea, vomiting, dyspepsia, flatulence. <span class="typehead">CNS:</span> Drug fever, headache, dizziness. <span class="typehead">Skin:</span> Rash, pruritus. <span class="typehead">Urogenital:</span> Vaginitis, genital pruritus. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Probenecid</b> decreases renal elimination of cefmetazole. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Elimination:</span> Excreted unchanged in urine. <span class="typehead">Half-Life:</span> 1.2 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Determine previous hypersensitivity to cephalosporins, penicillins, and history of other allergies, particularly to drugs,
            before therapy is initiated.
         </li>
<li>Lab tests: Perform culture and sensitivity tests before initiation of therapy and periodically during therapy. Therapy may
            be implemented pending test results. Monitor PT in patients with renal or hepatic disease or those receiving a long course
            of antibiotic therapy.
         </li>
<li>Assess for S&amp;S of superinfections (see Appendix F) caused by overgrowth of nonsusceptible organisms, particularly with prolonged
            use.
         </li>
<li>Promptly report loose stools or diarrhea because of risk of pseudomembranous colitis (see Appendix F). Older adults are especially
            susceptible. Drug may be discontinued.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report onset of loose stools or diarrhea even for several weeks after drug is discontinued.</li>
<li>Do not ingest alcohol within 24 h of drug as this may cause a disulfiram-like reaction (see Appendix F).</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>